Protalix BioTherapeutics Reports Full Year 2014 Financial Results and Provides Corporate
Protalix BioTherapeutics, Inc. (NYSE MKT:PLX) (TASE:PLX), today reported financial results for the year ended December 31, 2014 and provided an update on recent corporate developments.